Too little, too late : palliation and end stage liver disease

Article indépendant

CHEN, Hayley | JOHNSTON, Alexander | PALMER, Andrew | MICKENBECKER, Matthew | O'SULLIVAN, Timothy | CLARK, Paul

Background and Aim: End-stage liver disease is a leading cause of mortality. Fewer than 60% of patients with decompensated cirrhosis survive after 2 years, with patients often experiencing distressing symptoms impairing quality of life. Early advanced care planning and timely palliative care referral can improve quality of life and the end of life experience. We aimed to determine palliative care referral rates and patterns for patients admitted with decompensated cirrhosis, and to identify the factors associated with referral. Methods: This was a retrospective, single-center study undertaken at a metropolitan tertiary referral hospital. Patients admitted between the 1 June 2016 and 31 January 2019 with a Child–Pugh score of B or C, and a model for end-stage liver disease score = 15 were included. We assessed survival and compared those referred and not referred to palliative care, adjusting for lag-time to referral (Kaplan–Meier analysis). Results: One-hundred and sixteen admissions met eligibility criteria for referral. The median age at admission was 59 years, with 76% male participants. Only a fifth of eligible patients (25/116) were referred to palliative care. The median survival (from referral) for those referred to palliative care was 20 days, versus 148 days for those not referred. Conclusions: Despite benefits from timely referral, less than one quarter of palliative care eligible patients was referred. Referral appears reserved for those facing imminent death—surviving just under 3 weeks postreferral, yet mortality in nonreferred patients remained high (148-day median). Low rates and late referral are a missed opportunity to improve the end of life care for patients with end-stage liver disease.

http://dx.doi.org/10.1111/jgh.15499

Voir la revue «Journal of gastroenterology and hepatology»

Autres numéros de la revue «Journal of gastroenterology and hepatology»

Consulter en ligne

Suggestions

Du même auteur

Too little, too late : palliation and end sta...

Article indépendant | CHEN, Hayley | Journal of gastroenterology and hepatology

Background and Aim: End-stage liver disease is a leading cause of mortality. Fewer than 60% of patients with decompensated cirrhosis survive after 2 years, with patients often experiencing distressing symptoms impairing quality of...

De la même série

Palliative care in hepatocellular carcinoma

Article indépendant | LAUBE, Robyn | Journal of gastroenterology and hepatology

Hepatocellular carcinoma is a common cancer with a poor prognosis, associated with high economic costs and a significant burden of disease. While it is often asymptomatic in the early stages, patients may experience great discomfo...

Too little, too late : palliation and end sta...

Article indépendant | CHEN, Hayley | Journal of gastroenterology and hepatology

Background and Aim: End-stage liver disease is a leading cause of mortality. Fewer than 60% of patients with decompensated cirrhosis survive after 2 years, with patients often experiencing distressing symptoms impairing quality of...

Barriers to palliative care in hepatocellular...

Article indépendant | ABASSERI, Mostafa | Journal of gastroenterology and hepatology

Hepatocellular carcinoma (HCC) is a deadly and burdensome form of liver cancer with an increasing global prevalence. Its course is unpredictable as it frequently occurs in the context of underlying end-stage liver disease, and the...

Chargement des enrichissements...